Back to HUNTINGTON NATIONAL BANK HUNTINGTON NATIONAL BANK

PVCTPVCT
Showing 8 of 28 quarters

Position history for HUNTINGTON NATIONAL BANKHUNTINGTON NATIONAL BANK's holdings in PROVECTUS BIOPHARMACEUTICALS

HUNTINGTON NATIONAL BANK holds 1 shares of PVCT (PROVECTUS BIOPHARMACEUTICALS), worth $0 as of 2026-Q1.

Current Value

$0

Current Shares

1

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
1
0.0%
$00.0%$0.05
0
2025-Q4
Unchanged
1
0.0%
$00.0%$0.06
0
2025-Q3
Unchanged
1
0.0%
$00.0%$0.09
0
2025-Q2
Unchanged
1
0.0%
$00.0%$0.08
0
2025-Q1
Unchanged
1
0.0%
$00.0%$0.10
0
2024-Q4
Unchanged
1
0.0%
$00.0%$0.12
0
2024-Q3
Unchanged
1
0.0%
$00.0%$0.10
0
2024-Q2
Unchanged
1
0.0%
$00.0%$0.13
0

Other major holders of PVCT: BLACKROCK ADVISORS LLC, CAPTRUST FINANCIAL ADVISORS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used